The Evernorth Research Institute analyzed aggregated and anonymized data of almost 5 million insured individuals to understand the prevalence of "cardiodiabesity" — a condition which encompasses cardiovascular disease, type 2 diabetes and obesity.

We sat down with Adam Kautzner, a pharmacist and the president of Express Scripts, who discussed some of our recent endeavors to improve access to quality care in rural America.

An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while preserving choice and flexibility for providers and patients.

Health plans that address and manage complex chronic conditions such as cardiovascular disease, obesity, and diabetes have a competitive advantage.

The way women experience health and disease are unique through specific stages like pregnancy, menopause and more.

A well-designed fertility benefit helps members stay on treatment, reducing wasted dollars